close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Organon & Co. Common Stock (NY:OGN)

7.060 -0.630 (-8.19%)
Official Closing Price Updated: 7:00 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Organon & Co. Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
News headline image
Organon antaa koko henkilökunnalleen vapaapäivän oman terveytensä edistämiseksi kansainvälisenä naisten päivänä
”Koska Covid-19-pandemialla on edelleen suhteettoman suuri vaikutus naisiin, Organon kutsuu muita organisaatioita liittymään joukkoonsa ja olemaan 
Via EIN Presswire
News headline image
Organon Declares Paid Time Off for All Employees on International Women’s Day; Employees to Focus on Their Own Health in Recognition of Growing Women’s Health Inequity
From Organon & Co.
Via Business Wire
News headline image
Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 17, 2022
From Organon & Co.
Via Business Wire
News headline image
Earnings Scheduled For November 11, 2021 ↗
Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape... 
Via Benzinga
News headline image
Expert Ratings For Organon ↗
Analysts have provided the following ratings for Organon (NYSE:OGN) within th... 
Via Benzinga
News headline image
What 6 Analyst Ratings Have To Say About Organon ↗
Organon (NYSE:OGN) has observed the following analyst ratings within the last... 
Via Benzinga
News headline image
FDA Accepts Samsung Bioepis’ and Organon’s sBLA for their Citrate-Free, High-Concentration HUMIRA® (Adalimumab) Biosimilar Candidate
From Organon & Co.
Via Business Wire
News headline image
Organon To Present at the 40th Annual J.P. Morgan Healthcare Virtual Conference
From Organon & Co.
Via Business Wire
News headline image
Organon Completes Acquisition of Forendo Pharma
From Organon & Co.
Via Business Wire
News headline image
Warren Buffett Is Selling These Stocks ↗
Looking to make money moves like Warren Buffett? Want to know which stocks Buffett is selling? Interested in finding out why these stock sales might be a huge mistake? 
Via Talk Markets
News headline image
Tuesday Markets Coverage ↗
GE was up on hopes for cheaper oil. But most stocks were down on oil price hike fears. 
Via Talk Markets
News headline image
Novartis May Have Buyer(s) For Its Sandoz Unit - Report ↗
According to a German newspaper, Swedish-based investment group EQT and the Struengmann family of Germany are considering a joint move to purchase the Novartis AG... 
Via Benzinga
News headline image
Organon To Present at the Evercore ISI 4th Annual HealthCONx Conference
From Organon & Co.
Via Business Wire
News headline image
3 Recent Spin-Off Stocks Worth A Spot in Your Portfolio ↗
Spin-off stocks can be lucrative for shareholders in both legacy businesses and recently created public companies. Here are three to know. 
Via InvestorPlace
News headline image
Berkshire Exited Merck Before COVID Pill Boost; Trimmed Holdings In AbbVie, Bristol Myers In Q3 ↗
Warren Buffett's Berkshire Hathaway Inc (NYSE: BRK-A) cleared its stake in Merck & Co Inc (NYSE: MRK) in Q3, right on the eve of a significant stock... 
Via Benzinga
News headline image
Warren Buffet Takes A Stake In Royalty Pharma And Exits Merck — What You Need To Know ↗
Warren Buffet's Berkshire Hathaway added more than 13 million shares. 
Via Investor's Business Daily
News headline image
Johnson & Johnson Pops As It Announces The Biggest Split In Health Care ↗
Johnson & Johnson will split its consumer health unit into a publicly traded company. 
Via Investor's Business Daily
News headline image
Veteran's Day ↗
Stock markets took a tumble today across the board, but not as far down as at the opening. 
Via Talk Markets
News headline image
Lower Sales Impact Organon's Q3 Margins; Acquires Forendo Pharma For Over $900M ↗
Organon & Co (NYSE: OGN) has reported Q3 sales of $1.6 billion, down 1% Y/Y, slightly higher than the consensus of $1.58 billion. Women's Health declined... 
Via Benzinga
News headline image
Organon Beat Quarterly Forecasts, Unveiled Takeover — Here's Why Shares Fell ↗
Organon topped forecasts on Thursday and announced its plan to buy Forendo Pharma. 
Via Investor's Business Daily
News headline image
Organon Reports Results for the Third Quarter Ended September 30, 2021
From Organon & Co.
Via Business Wire
News headline image
Organon to Acquire Forendo Pharma
From Organon & Co.
Via Business Wire
News headline image
Why Merck's Strong Outlook For 2021 Could Become Even More Bullish ↗
Merck issued upbeat guidance for 2021 that could grow if Covid pill molnupiravir gains authorization. 
Via Investor's Business Daily
News headline image
Organon To Report Third Quarter Results and Host Conference Call on November 11, 2021
From Organon & Co.
Via Business Wire
News headline image
Europe's Unicorns ↗
After markets jumped yesterday, we saw a lot of bounce today although gold fell back a bit. 
Via Talk Markets
News headline image
Organon Launches New Fertility Journey Website as Part of Ongoing Commitment to Help Address the Needs of Women
From Organon & Co.
Via Business Wire
News headline image
Organon Receives FDA Clearance for Technological Updates to the Jada® System, a Medical Device Intended to Control Postpartum Hemorrhage
From Organon & Co.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021 ↗
Upgrades For State Street Corporation (NYSE: 
Via Benzinga
News headline image
Organon Aims to Ignite Worldwide Conversation Around Unplanned Pregnancy
From Organon & Co.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2021 ↗
Upgrades For Chatham Lodging Trust (NYSE: 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today